• Produktbild: Treatment Of Early Diabetes
  • Produktbild: Treatment Of Early Diabetes
Band 119

Treatment Of Early Diabetes

Fr. 137.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.12.2012

Herausgeber

R. Camerini-Davalos

Verlag

Springer Us

Seitenzahl

532

Maße (L/B/H)

24.4/17/3 cm

Gewicht

941 g

Auflage

Softcover reprint of the original 1st ed. 1979

Sprache

Englisch

ISBN

978-1-4615-9112-2

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.12.2012

Herausgeber

R. Camerini-Davalos

Verlag

Springer Us

Seitenzahl

532

Maße (L/B/H)

24.4/17/3 cm

Gewicht

941 g

Auflage

Softcover reprint of the original 1st ed. 1979

Sprache

Englisch

ISBN

978-1-4615-9112-2

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Treatment Of Early Diabetes
  • Produktbild: Treatment Of Early Diabetes
  • Early Diabetes: Definition, Present Concept.- Early Diabetes. Concept. Terminology.- Early Stages of Diabetes: Definitions and Present Concepts.- Prediabetes in the Pima Indians.- The Prognosis of Insulin Dependent Diabetes Mellitus and the Importance of Supervision.- Discussion.- Genetic Influences on Islet Cell Function.- HLA System.- HLA and the Genetic Aspects of the Predisposition to Juvenile Diabetes Mellitus. A Follow-Up.- HLA Studies in Diabetics.- Discussion.- Familial Patterns of Inheritance.- On the Genetic Heterogeneity of Juvenile Hyperglycemia.- Familial Patterns of Inheritance of Diabetes Mellitus. Maturity-Onset Type Diabetes of Young People (MODY).- Discussion.- Metabolic Aspects of Islet Cell Function.- Phosphate Translocations During Secretory Stimulation of Pancreatic Islets.- The Role of Phosphoenolpyruvate and Lactate Production in Insulin Secretion.- Effects of Insulinotropic Agents on Cationic Fluxes in Islet Cells.- Glucose-Induced Changes of the Membrane Potential of Pancreatic B-Cells: Their Significance for the Regulation of Insulin Release.- Discussion.- Abnormal Development of the Pancreas.- Effect of Maternal Carbohydrate Intolerance on the Development of the Autonomic Innervation of the Fetal Rat Pancreas.- Discussion.- Environmental Factors Influencing Islet Cell Function.- Nutritional.- Suppression of Insulin Secretion by Protein Deprivation in Obesity.- Discussion.- Viruses.- Virus-Induced Diabetes Mellitus: Infection of Mice with Variants of Encephalomyocarditis Virus, Coxsackievirus B4, and Reovirus Type 3.- Autoimmunity.- Immunological Aspects of Diabetes Mellitus.- Detection and Possible Functional Influence of Antibodies Directed Against the Pancreatic Islet Cell Surface.- Discussion.- Patterns of Insulin Secretion.- Heterogeneity of Insulin Responses in Maturity-Onset Type Diabetes (MOD) and in Maturity-Onset Type Diabetes of Young People (MODY).- Progression of Early Diabetes.- Insulin Resistance and Insulin Secretion in Patients with Chemical Diabetes: Implications Concerning the Pathogenesis of Idiopathic Diabetes Mellitus.- Inquiries into the Pathogenesis of Gestational Diabetes.- Effect of Intravenous Glucose, Leucine and Arginine on Concentration of Insulin in Maternal and Umbilical Cord Serum.- Discussion.- Mechanism of Salvaging Beta Cell Function.- Beta Cell Dysfunction in Maturity-Onset Diabetes: Reversible Loss of Glucose-Induced Insulin Secretion with Retention of Response to Arginine.- Improvement of Insulin Secretion in Diabetics by a Prostaglandin Synthesis Inhibitor.- Discussion.- Diet Therapy.- Decreased Food Intake.- Effect of Diet Limitation on Development of Diabetes in Non-Hyperphagic Prediabetic Chinese Hamsters.- Riboflavin in CHO Metabolism.- The Role of Riboflavin in Carbohydrate Metabolism.- Discussion.- Responses to Different Complex Carbohydrates.- Effect of Variations in Carbohydrate Intake on Plasma Glucose, Insulin and Triglyceride Responses in Normal Subjects and Patients with Chemical Diabetes.- High Carbohydrate, High Fiber Diets for Patients with Diabetes.- Dietary Fiber and Diabetic Therapy: A Progressive Effect with Time.- Discussion.- High Myoinositol.- Dietary myo-Inositol and Diabetic Neuropathy.- Discussion.- Long Term Treatment with Insulin.- Animals.- Effect of Insulin Treatment on the Mesangial Structure of KK Mice.- Humans.- Insulin Treatment for Adult Onset Diabetes: A Report of the University Group Diabetes Program.- Refuting the UGDP Conclusion That Insulin Treatment Does Not Prevent Vascular Complications in Diabetes.- Discussion.- New Insulins.- New Synthetic Insulins.- Differential Response of Insulin-Dependent Diabetics to Infusions of Bovine and Highly-Purified Porcine Insulins: A Preliminary Report.- Discussion.- Enzyme Inhibitors.- Delay of Carbohydrate Absorption by Inhibitors of Intestinal ?-Glucosidases.- Inhibition of Polyol Pathway Activity in Diabetic and Galactosemic Rats by the Aldose Reductase Inhibitor CP-45,634.- Discussion.- Mechanism of Action of Oral Compounds.- Genetic Control of Tolbutamide Metabolism in Humans.- Insulin Resistance in Patients with Insulin Independent Diabetes Mellitus: Partial Amelioration by the Sulfonylurea Glipizide.- Discussion.- Long Term Treatment with Oral Compounds.- Animals.- Diabetic Glomerulosclerosis in KK Mice and Its Prevention by Glyburide and Pyridinolcarbamate.- Discussion.- Humans.- Long Term Treatment of Asymptomatic Diabetes.- Metabolic Fate, Vascular Outcome and the Effect of Treatment in Borderline Diabetics.- Long-Term Treatment of Subjects with Borderline Glucose Tolerance.- Discussion.- New Oral Agents: Comparisons.- Glipizide: A New Second Generation Sulfonylurea.- Effect of the Oral Hypoglycemic Agent Pirogliride Tartrate on Insulin and Glucagon Secretion In Vivo and In Vitro.- Gliclazide in the Treatment of Diabetic Retinopathy.- Discussion.- Exercise.- The Effect of Repetitive Exercise on Daily Control of Glycemia in Insulin-Dependent Diabetic Patients.- Discussion.- Substitution of Islet Cell Function.- Transplant.- Isolation and Preservation In Vitro of Human Pancreatic Islets Intended for Transplantation.- The Development, Enhancement and Reversibility of Diabetic Glomerulopathy.- Discussion.- Newer Delivery Systems.- Substitution of Islet-Cell Function with “Open-Loop” Insulin Infusion Systems.- Newer Insulin Delivery Systems: Continuous Subcutaneous Insulin Infusion.- Discussion.- Mechanical Devices.- Substitution of Islet Cell Function by Mechanical Device: Extracorporeal Artificial Pancreas.- Glycemic Normalization Using a Preprogrammed Insulin Delivery Device in Unrestrained Diabetic Dogs.- Discussion.- List of Participants.